Table 1.
Total (n = 213) | |
---|---|
Median age (range; n = 189) | 64 (31-84) |
Male (%) | 160/211 (76) |
Performance status >1 (%) | 35/176 (20) |
Blastoid (%) | 20/212 (9) |
MIPI (%) | |
Low | 59/138 (43) |
Intermediate | 34/138 (25) |
High | 45/138 (33) |
Treatment | |
R-CHOP | 147 |
Observation | 39 |
Other | 5 |
Unknown | 22 |
HSCT/AUTO | 14 |
MCL tumor samples from 213 patients were obtained from patients living in British Columbia.
MIPI, MCL International Prognostic Index.